Time: 4:00 – 5:00 pm. Refreshments from 3:45 pm. Non-members welcome (as always). No RSVP required to attend the talk. Please RSVP to [email protected] by COB Monday 1st September if you would like to join us for dinner with the speaker at a nearby restaurant http://www.sagorestaurant.com.au/
Location: Room KG-Q430, Institute of Health and biomedical Innovation(IHBI), 60 Musk Avenue, Kelvin Grove Campus, Queensland University of Technology. Click here for a map.
Title: Effect of Tamiflu on mortality: can it be explained by time-dependent bias?
Speaker: Dr Mark Jones, UQ School of Population health
Dr Mark Jones is a senior research fellow in biostatistics at the UQ School of Population Health. He teaches biostatistics courses run by the Biostatistical Collaboration of Australia (BCA) and has been involved in a Cochrane review of antivirals for influenza since 2005. The Cochrane team for the review comprises researchers from UK, USA, Italy, Japan and Australia. He is currently reviewing observational mortality studies of Tamiflu conducted during the 2009 influenza pandemic.
Abstract: Tamiflu (oseltamivir) is a neuraminidase inhibitor, an antiviral used for treatment of influenza. Since approval in 2000, Tamiflu has become an international blockbuster with 130 million people taking it and $18b earned by the manufacturer. A recent Cochrane review has shown this drug has very modest efficacy and potentially serious toxic effects. In this presentation I will describe an unpublished review of observational studies of Tamiflu conducted during the 2009 influenza pandemic. In particular I will show how an apparent protective effect on mortality can be explained by time-dependent bias.
|Time:||4:00 pm - 5:00 pm|